Skip to main content

Advertisement

Log in

Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature

  • Original Article
  • Published:
Neurosurgical Review Aims and scope Submit manuscript

Abstract

Fractionated radiotherapy (FRT) and gamma knife stereotactic radiosurgery (GKSRS) are used as adjuvant therapies to surgical resection for functional and non-functional pituitary adenomas, although their optimum role in the treatment algorithm, as well as long-term safety and efficacy, still awaits further study. We report a single center experience with 33 patients with non-functional (16 patients), ACTH- (five patients), GH- (four patients), or prolactin-secreting (eight patients) tumors treated with FRT or SRS. The median tumor diameter was 1.9 cm, and the median follow-up was 36 months. For GKSRS, the median dosage was 16 Gy for non-functional adenomas and 23 Gy for hormone-secreting tumors. The median total dose for FRT was 50.4 Gy over 28 fractions (median). Two patients (6%) demonstrated radiographic evidence of tumor progression, three patients (9%) demonstrated radiation-induced visual field deficits on neuro-ophthalmic evaluation, and two patients (6%) suffered from radiation-induced hypopituitarism. Biochemical control, defined as normalized hormone values in the absence of medical therapy, was achieved in five out of eight prolactinoma patients and two out of five patients with Cushing’s disease, but none of the four patients with acromegaly. These results are presented with a review of the relevant literature on the differential characteristics of FRT versus SRS in the treatment of functional and non-functional pituitary adenomas and validate postoperative irradiation as a potentially safe and effective means for tumor control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Adler JR, Gibbs IC, Puataweepong P, Chang SD (2008) Visual field preservation after multisession Cyberknife radiosurgery for perioptic lesions. Neurosurgery 62:733–743

    Article  PubMed  Google Scholar 

  2. Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna S, Luton JP, Bertherat J (2000) Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 85:3779–3785

    Article  PubMed  CAS  Google Scholar 

  3. Biermasz N, van Dulken H, Roelfsema F (2000) Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 85:2476–2482

    Article  PubMed  CAS  Google Scholar 

  4. Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P, Cortet-Rudelli C, Kuhn JM, Conte-Devolx B, Regis J, Brue T (2009) Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94:3400–3407

    Article  PubMed  CAS  Google Scholar 

  5. Chang EF, Zada G, Kim S, Lamborn KR, Quinones-Hinojosa A, Tyrrell JB, Wilson CB, Kunwar S (2008) Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J Neurosurg 108:736–745

    Article  PubMed  Google Scholar 

  6. Chen CC, Chapman P, Petit J, Loeffler J (2007) Proton radiosurgery in neurosurgery. Neurosurg Focus 23:E4

    Article  PubMed  Google Scholar 

  7. Estrada J, Boronat M, Mielgo M, Magallon R, Millan I, Diez S, Lucas T, Barcelo B (1997) The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing’s disease. N Engl J Med 336:172–177

    Article  PubMed  CAS  Google Scholar 

  8. Feigl GC, Bonelli CM, Berghold A, Mokry M (2002) Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg 97:415–421

    PubMed  Google Scholar 

  9. Ghostine S, Ghostine MS, Johnson WD (2000) Radiation therapy in the treatment of pituitary tumors. Neurosurg Focus 24:E8

    Article  Google Scholar 

  10. Hoybye C, Rahn T (2009) Adjuvant gamma knife radiosurgery in non-functioning pituitary adenomas; low risk of long-term complications in selected patients. Pituitary 12:211–216

    Article  PubMed  Google Scholar 

  11. Hoybye C, Grenbäck E, Rähn T, Degerblad M, Thorén M, Hulting AL (2001) Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 49:284–292

    Article  PubMed  CAS  Google Scholar 

  12. Izawa M, Hayashi M, Nakaya K, Satoh H, Ochiai T, Hori T, Takakura K (2000) Gamma knife radiosurgery for pituitary adenomas. J Neurosurg 93:19–25

    Article  PubMed  Google Scholar 

  13. Izawa M, Chernov M, Hayashi M, Nakaya K, Kamikawa S, Kato K, Higa T, Ujiie H, Kasuya H, Kawamata T, Okada Y, Kubo O, Iseki H, Hori T, Takakura K (2007) Management and prognosis of cysts developed on long-term follow-up after gamma knife radiosurgery for intracranial arteriovenous malformations. Surg Neurol 68:400–406

    Article  PubMed  Google Scholar 

  14. Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML (2007) Gamma knife surgery for Cushing’s disease. J Neurosurg 106:980–985

    Article  PubMed  Google Scholar 

  15. Jagannathan J, Sheehan J, Pouratian N, Laws EJ, Steiner L, Vance M (2008) Gamma knife radiosurgery for acromegaly: outcomes after failed transsphenoidal surgery. Neurosurgery 62:1262–1269

    Article  PubMed  Google Scholar 

  16. Kokubo M, Sasai K, Shibamoto Y, Aoki T, Oya N, Mitsumori M, Takahashi J, Hashimoto N, Hiraoka M (2000) Long-term results of radiation therapy for pituitary adenoma. J Neurooncol 47:79–84

    Article  PubMed  CAS  Google Scholar 

  17. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G (2000) Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab 85:1287–1289

    Article  PubMed  CAS  Google Scholar 

  18. Laws EJ, Vance M (1999) Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin N Am 10:327–336

    PubMed  Google Scholar 

  19. Liscak R, Vladyka V, Marek J, Simonova G, Vymazal J (2007) Gamma knife radiosurgery for endocrine-inactive pituitary adenomas. Acta Neurochir (Wien) 149:999–1006

    Article  CAS  Google Scholar 

  20. Losa M, Valle M, Mortini P, Franzin A, di Passano CF, Cenzato M, Bianchi S, Picozzi P, Giovanelli M (2004) Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. J Neurosurg 100:438–443

    Article  PubMed  Google Scholar 

  21. Losa M, Gioia L, Picozzi P, Franzin A, Valle M, Giovanelli M, Mortini P (2008) The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 93:2546–2552

    Article  PubMed  CAS  Google Scholar 

  22. Mahmoud-Ahmed A, Suh J (2002) Radiation therapy for Cushing’s disease: a review. Pituitary 5:175–80

    Article  PubMed  CAS  Google Scholar 

  23. Minniti G, Jaffrain-Rea M-L, Osti M, Esposito V, Santoro A, Solda F, Gargiulo P, Tamburrano G, Enrici R (2005) The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol (Oxf) 62:210–216

    Article  Google Scholar 

  24. Nishioka H, Hirano A, Haraoka J, Nakajima N (2002) Histological changes in the pituitary gland and adenomas following radiotherapy. Neuropathology 22:19–25

    Article  PubMed  Google Scholar 

  25. Paek SH, Downes MB, Bednarz G, Keane WM, Werner-Wasik M, Curran JWJ, Andrews DW (2005) Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Int J Radiat Oncol Biol Phys 61:795–808

    Article  PubMed  Google Scholar 

  26. Pamir MN, Kiliç T, Belirgen M, Abacioglu U, Karabekiroglu N (2007) Pituitary adenomas treated with gamma knife radiosurgery: volumetric analysis of 100 cases with minimum 3 year follow-up. Neurosurgery 61:270–280

    Article  PubMed  Google Scholar 

  27. Pollock BE, Carpenter PC (2003) Stereotactic radiosurgery as an alternative to fractionated radiotherapy for patients with recurrent or residual nonfunctioning pituitary adenomas. Neurosurgery 53:1086–1094

    Article  PubMed  Google Scholar 

  28. Pollock BE, Young WF (2002) Stereotactic radiosurgery for patients with ACTH-producing pituitary adenomas after prior adrenalectomy. Int J Radiat Oncol Biol Phys 54:839–841

    Article  PubMed  Google Scholar 

  29. Pollock BE, Jacob JT, Brown PD, Nippoldt TB (2007) Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg 106:833–836

    Article  PubMed  CAS  Google Scholar 

  30. Pollock BE, Brown P, Nippoldt T, Young WJ (2008) Pituitary tumor type affects the chance of biochemical remission after radiosurgery of hormone-secreting pituitary adenomas. Neurosurgery 62:1271–1276

    Article  PubMed  Google Scholar 

  31. Pollock BE, Cochran J, Natt N, Brown PD, Erickson D, Link MJ, Garces YI, Foote RL, Stafford SL, Schomberg PJ (2008) Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int J Radiat Oncol Biol Phys 70:1325–1329

    Article  PubMed  Google Scholar 

  32. Pouratian N, Sheehan J, Jagannathan J, Laws ER, Steiner L, Vance ML (2006) Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery 59:255–266

    Article  PubMed  Google Scholar 

  33. Sheehan JM, Vance ML, Sheehan JP, Ellegala DB, Laws ER (2000) Radiosurgery for Cushing’s disease after failed transsphenoidal surgery. J Neurosurg 93:738–740

    Article  PubMed  CAS  Google Scholar 

  34. Sheehan JP, Niranjan A, Sheehan JM, Jane JA, Laws ER, Kondziolka D, Flickinger J, Landolt AM, Loeffler JS, Lunsford LD (2005) Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102:678–686

    Article  PubMed  Google Scholar 

  35. Sheehan JP, Jagannathan J, Pouratian N, Steiner L (2006) Stereotactic radiosurgery for pituitary adenomas: a review of the literature and our experience. Front Horm Res 34:185–205

    Article  PubMed  Google Scholar 

  36. Stafford S, Pollock B, Leavitt J, Foote R, Brown P, Link M, Gorman D, Schomberg P (2003) A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 55:1177–1181

    Article  PubMed  Google Scholar 

  37. Vladyka V, Lišcák R, Novotný JJ, Marek J, Ježková J (2003) Radiation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas. Neurosurgery 52:309–317

    Article  PubMed  Google Scholar 

  38. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307–314

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported in part by a grant from the Salisbury Foundation to DR.

Financial disclosure information

The authors in this manuscript have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Lim.

Additional information

Comments

Miguel A. Arraez, Malaga, Spain

This paper carries out the study of 33 patients that underwent radiotherapy treatment for invasive or recurrent pituitary adenoma. In the recurrent tumor, the mainstay of treatment in such a situation is radiotherapy once reoperation has been ruled out (sterotactic fraccionated radiotherapy or stereotactic radiosurgery). These modalities have different context in accordance to the volume and proximity to critical organs like optic pathways. Although this study lacks of a large number of cases and long follow-up, it depicts the usefulness of these modalities of stereotactic radiation to control pituitary adenomas. The figures of control are in full accordance with the previous published articles for non-secreting tumors. In secreting pituitary adenomas, a very acceptable rate of biochemical control has been obtained. Some figures are in disagreement to the previously published data regarding the cure of acromegaly patients but, as the authors also stated, a longer period is needed to properly assess the usefulness of radiation therapy in GH-secreting tumors. Another issue of interest is the possibility of radiation without previous surgery. In this series, it was done after rejection of the surgical treatment for the patients. Undoubtedly, the debate about the possibility of elective radiation arises as first choice treatment for selected cases. The potential toxicity should be also taken into account. The 10% figures of delayed optic damage must lead us to the reflection for appropriate case selection and modality of treatment. The possibility of hypopituitarism mustn’t be forgotten whose low figures in this series are also attributed to a short follow-up.

Francesco DiMeco, Ida Milanesi, Marcello Marchetti, Milan, Italy

Radiation therapy for pituitary adenomas is still a debated and controversial topic. Previous reports have shown that conventional radiation is effective in tumor growth control and hormonal normalization.

Radiosurgery, while limiting irradiation and potential damages to the normal tissue, raises concerns about possible post-treatment hypopituitarism and visual function worsening. In addition, it carries potential risks of hyatrogenic tumors development or cognitive function impairment. The present article tries to address these issues showing good results with acceptable side effects. However, higher powered studies with longer follow-up are needed in order to corroborate these findings.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sun, D.Q., Cheng, J.J., Frazier, J.L. et al. Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature. Neurosurg Rev 34, 181–189 (2011). https://doi.org/10.1007/s10143-010-0285-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10143-010-0285-2

Keywords

Navigation